Formulation Strategies to Optimize the In Vitro Release of Fenbendazole from Immediate-Release Tablets Containing Amorphous Hydroxypropyl-β-Cyclodextrin Inclusion Complexes
Background/Objectives: The aim of this study is to obtain new inclusion complexes of fenbendazole (FEN) with hydroxypropyl-β-cyclodextrin (HP-β-CD) in order to optimize the in vitro release profile of fenbendazole from immediate-release tablets. Methods: Inclusion complexes and solid dispersions were prepared by coprecipitation, lyophilization, and kneading at 1:0.25 and 1:0.5 (FEN:HP-β-CD) sub-stoichiometric molar ratios. Physical mixtures were prepared for comparison. Both physical mixtures and inclusion complexes were subsequently evaluated using physicochemical and pharmacotehnical methods. Results: Physicochemical analysis (FTIR, XRD, and TG/DTA) showed that lyophilization successfully induced solid-state amorphization of the drug at both ratios. Directly compressed tablets exhibited excellent mechanical properties, with crushing strength ranging from 65.1 ± 2.4 N (F3) to 87.4 ± 2.9 N (F2) and 98.2 ± 3.5 N (F1), friability below 0.7%, and rapid disintegration (58 ± 3.2 s for F1, 69 ± 4.1 s for F2, and 77 ± 4.5 s for F3). In vitro dissolution was strongly medium-dependent: at pH 1.2, cyclodextrin-based tablets achieved near-complete dissolution within 60 min (Q60 = 96.8 ± 2.1, DE% = 81.8 ± 1.9% for F1; Q60 = 99.5 ± 1.8%, DE% = 71.4 ± 2.3% for F2), compared with the uncomplexed drug (Q60 = 63.3 ± 2.4%, DE% = 47.5 ± 1.7% for F3). At pH 4.5 and 6.8, drug release plateaued below 15% and 38%, respectively, due to non-sink saturation constraints. Conclusions: This study provides in vitro proof of concept that sub-stoichiometric amorphization with HP-β-CD, coupled with direct compression, overcomes the gastric dissolution barrier of fenbendazole, establishing a solid biopharmaceutical basis for future in vivo bioavailability and stability evaluations.
Authors
- Ancuța Cătălina Fița (ORCID: https://orcid.org/0000-0002-4705-4204)
- Daniela Cristina Culita (ORCID: https://orcid.org/0000-0001-9289-5443)
- Veronica Brătan (ORCID: https://orcid.org/0000-0002-4625-7827)
- Ramona Pârvănescu (ORCID: https://orcid.org/0009-0000-3187-3064)
- Vasile-Adrian Surdu (ORCID: https://orcid.org/0000-0002-4207-5380)
- Emma Adriana Ozon
- Adina Magdalena Musuc (ORCID: https://orcid.org/0000-0002-6935-8065)
- Ion Mircioiu (ORCID: https://orcid.org/0000-0002-6348-0414)
- Codruţa Şoica (ORCID: https://orcid.org/0000-0001-9029-1232)
- Cristina Maria Trandafirescu
Institutions
- Titu Maiorescu University (RO)
- Carol Davila University of Medicine and Pharmacy (RO)
- Transylvania University of Brașov (RO)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Romanian Academy (RO)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/pharmaceutics18111490
- Primary Topic
- Drug Solubulity and Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00